Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-dose recombinant FSH (150 IU vs 225 IU) for ovarian stimulation in IVF predicted low/intermediate responders
2006-001143-59Phase 4Completed
- Sponsor
- School of Human Development
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of follicle-stimulating hormone in female infertility (2 arms), sponsored by School of Human Development. Primary endpoint: ongoing pregnancy rate. Started May 2006; status: completed.
02
Drugs
follicle-stimulating hormone
03
Conditions
female infertility
Beyond the preview
Go deeper on 2006-001143-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001143-59.